← Open Payments lookup

MELISSA VOLTZ: Open Payments

NPI 1598053563 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,306 in 33 payments from 14 companies in 2025. Trend: 2023 $575 · 2024 $1,717 · 2025 $2,306

Food & beverage: $1,804Consulting: $403Education: $100
CompanyPaymentsAmount
Eisai Inc.1$403
Janssen Scientific Affairs, LLC4$342
Janssen Biotech, Inc.7$275
PFIZER INC.4$252
GENZYME CORPORATION2$245
Bayer Healthcare Pharmaceuticals Inc.5$186
Edwards Lifesciences Corporation1$125
Madrigal Pharmaceuticals1$123
Gilead Sciences, Inc.1$121
Illumina, Inc.2$105

Products named: Lenvima, ERLEADA, XTANDI, AKEEGA, Kerendia, RYBREVANT, DUPIXENT, REZDIFFRA.

Industry payments across LA — which companies pay providers there.